Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.395 HKD | 0.00% |
|
+8.22% | -14.13% |
Jun. 26 | Simcere Zaiming and Mabpharm Limited Announce Approval of Cetuximab Beta in China by the NMPA | CI |
Jun. 25 | Simcere-Mabpharm Cancer Drug Gets Marketing Approval in China | MT |
- Stock Market
- Equities
- 2181 Stock
- News Mabpharm Limited
- Trading Ideas